ClinicalTrials.Veeva

Menu
N

Novatrials | Charlestown, Australia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Maridebart Cafraglutide
Pentosan Polysulfate Sodium
Olpasiran
Semaglutide
Povorcitinib
Survodutide
BI 456906

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 10 total trials
Locations recently updated

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) (EMBARQ-CSU2)

The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urtic...

Enrolling
Chronic Spontaneous Urticaria
Biological: Matching placebo
Biological: barzolvolimab

This study has 2 parts: First part is the main study and second part is the extension study. During the main study participants will receive 1 of 4 s...

Active, not recruiting
Obesity
Drug: Cagrilintide
Drug: Semaglutide

This Phase 2a clinical study (GIANTS-1) aims to evaluate a novel dual-combination strategy using GI-102 and GIB-7 to address key pathological feature...

Enrolling
Cancer Survivors
Elderly
Combination Product: GI-102 in combination with GIB-7
Combination Product: Placebo

The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.

Enrolling
Prurigo Nodularis
Drug: Placebo
Drug: Povorcitinib

The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared wi...

Enrolling
Osteoarthritis, Knee
Drug: Pentosan Polysulfate Sodium twice weekly
Drug: Placebo

This study is open to adults who are at least 18 years old and have a body mass index (BMI) of 27 kg/m2 or more. People can take part if they have ca...

Active, not recruiting
Obesity
Drug: Placebo
Drug: survodutide

The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of car...

Enrolling
Overweight
Atherosclerotic Cardiovascular Disease
Drug: Maridebart Cafraglutide
Drug: Placebo

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Obesity
Drug: Placebo
Drug: Maridebart Cafraglutide
Locations recently updated

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardi...

Enrolling
Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo
Status recently updated

This is an early-stage clinical trial to determine a safe and effective dose for Tivoxavir Marboxil (TRX-100) in patients with mild to moderate Influ...

Withdrawn
Active, not recruiting
Influenza
Drug: TRX-100
Drug: Standard of Care (SOC)

Trial sponsors

Amgen logo
Boehringer Ingelheim logo
Celldex Therapeutics logo
G
Incyte logo
Novo Nordisk logo
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems